Heart medtech in $40m raise to fund flagship project
SYDNEY: Anteris Technologies, the heart medtech where L1 Capital owns 16.9 per cent, launched a
SYDNEY: Anteris Technologies, the heart medtech where L1 Capital owns 16.9 per cent, launched a